Other studies found that rGel/BLyS induced cell death of the activated B cell (ABC) subtype of DLBCL was dependent upon disruption of other signaling pathways, such as NF-κB, Stat3 and IL-6R [27], [28], [30]. The gene discussed is STAT3; the disease is diffuse large B-cell lymphoma.